drugset / Trial / NCT05164627
Dexmedetomidine Versus Magnesium Infusion in Reducing Agitations in Pediatric Patients Undergoing Adenotonsillectomy
RandomizedParallel-groupOpen-labelPrevention
Summary
The aim of this study is evaluating the efficacy and safety of dexmedetomidine versus Magnesium for reducing emergence agitation after adenotonsillectomy in children. Secondary outcome is to reduce child needs for analgesics and to reduce their dose.
Timeline
- Start
- 2021-01-08
- Primary completion
- 2022-11-07
- Completion
- 2022-12-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Dexmedetomidine | Other / unclassified | 0.2 ug/kg | — |
| Comparator | Magnesium Sulfate | Other / unclassified | 10 mg/kg | — |
Indications
No indication recorded.